Browse our anti-Dynamin 1 (DNM1) Antibodies

Human Dynamin 1 (DNM1) interaction partners

1. Three genes in our epilepsy cohort (COQ4 (show COQ4 Antibodies), DNM1, and PURA (show PURA Antibodies)), accounting for 14% (3/21) of all novel genetic etiologies identified in patients with epilepsy, were subsequently confirmed in independent publications.

2. Study delineates the phenotypic spectrum of DNM1 encephalopathy, an emerging disease of synaptic vesicle fission characterized by severe to profound developmental delay, infantile-onset epilepsy beginning with infantile spasms, and movement disorder. The genetic landscape of DNM1 encephalopathy is notable for the recurrent c.709C>T (p.Arg237Trp) variant and localization of mutations to specific domains of the protein.

3. CLCb/Dyn1 (show DNM1L Antibodies)-dependent adaptive clathrin-mediated endocytosis selectively altered EGF receptor (show EGFR Antibodies) trafficking.

4. interation of DG with laminin and dynamin is involved in the regulation of AQP4 (show AQP4 Antibodies) internalization

5. Down-regulation of Dyn1 (show DNM1L Antibodies) activity enhances extracellular Nme1 (show NME1 Antibodies) in human colon tumor cell lines.

6. Hypoxic down-regulation of constitutive endocytosis is HIF-independent, and involves caveolin-1 (show CAV1 Antibodies)-mediated inhibition of dynamin-dependent, membrane raft endocytosis.

7. study reports 2 patients with early onset epileptic encephalopathy possessing de novo DNM1 mutations; detected the novel mutation c.127G>A (p.Gly43Ser) in a patient with Lennox-Gastaut syndrome, and a recurrent mutation c.709C>T (p.Arg237Trp) in a patient with West syndrome

8. The rare variants in DNM1 were significantly associated with smoking status.

9. Data indicate that stimulation of the dynamin GTPase activity by SH3 domains is determined by its middle domain.

10. molecular simulations corroborate the bimodal character of dynamin action and indicate radial and axial forces as dominant, although not independent, drivers of hemi-fission and fission membrane- transformations, respectively

Mouse (Murine) Dynamin 1 (DNM1) interaction partners

1. reveal functional differences between Dnm1a and Dnm1b isoforms in the presence of a challenge, i.e. toxic Dnm1(Ftfl), while reinforcing its effect explicitly in this model of severe pediatric epilepsy

2. Dynamin may facilitate Fas (show FAS Antibodies)-mediated apoptotic death in the brain, and Hsp70 (show HSP70 Antibodies) may protect by preventing this trafficking.

3. These results suggested that dynamin 1 was susceptible to the aging process, and that a reduction in dynamin 1 may result in hippocampaldependent memory deficits by disrupting endocytosis and the release of neurotransmitters.

4. Tissue-specific dynamin-1 deletion at the calyx of Held decreases short-term depression through a mechanism distinct from vesicle resupply.

5. findings support a role for HTT (show HTT Antibodies) on dynamin 1 function and ER homoeostasis. Proteolysis-induced alteration of this function may be relevant to disease.

6. the identification of the oligomerization cycle of dynamin is an attractive potential therapeutic target to treat chronic kidney diseases .

7. In the developing neurons, there is a dynamin 1-, dynamin 3- and clathrin-independent pathway of synaptic vesicle recycling mediated by bulk endocytosis.

8. Using an inducible knockout mouse model to generate dynamin 1- and 2-deficient primary osteoclast precursors and myoblasts, it was shown that fusion of both cell types requires dynamin.

9. Dynamin 1 is required for memory formation.

10. As low-level expression of the dynamin 3 (show DNM3 Antibodies) gene in these cells could not be excluded, we have now engineered dynamin 1, 2 and 3 triple KO (TKO (show MRPS12 Antibodies)) fibroblasts.

Horse (Equine) Dynamin 1 (DNM1) interaction partners

1. Equine herpesvirus type 1 pUL56-induced MHC-I endocytosis required dynamin and tyrosine kinase but was independent of clathrin and caveolin-1, the main constituents of the clathrin- and raft/caveola-mediated endocytosis pathways, respectively.